Age-associated changes in cardiac gene expression after preconditioning

Anesthesiology

Volumn 111, Issue 5, 2009, Pages 1052-1064

  Liu, Lixin ^a   Zhu, Jiang ^a   Glass, Peter S A ^a   Brink, Peter R ^a   Rampil, Ira J ^b   Rebecchi, Mario J ^a  

^a Department of Anesthesiology ^*

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ARNT1 PROTEIN; BIRC3 PROTEIN; CSF1 PROTEIN; CYSTEINE RICH PROTEIN 61; CYTOKINE; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HAMP PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MYELOID DIFFERENTIATION FACTOR 88; NUCLEIC ACID BINDING PROTEIN; PHLDA1 PROTEIN; PROTEIN; REG3G PROTEIN; RRAD PROTEIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BTG2; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE REGULATION; CELL DEATH; CELL MIGRATION; COHORT ANALYSIS; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION REGULATION; GROUPS BY AGE; HEART; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RNA EXTRACTION; TRANSCRIPTION REGULATION;

EID: 70350435278     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181bbcb2a     Document Type: Article

References (59)

1. Wei JY: Age and the cardiovascular system. N Engl J Med 1992; 327:1735-1739
2. Lakatta EG: Research agenda for cardiovascular aging: Humans to molecules. Am J Geriatr Cardiol 2000; 9:251-262
3. Pollack JA, Skvorak JP, Nazian SJ, Landon CS, Dietz JR: Alterations in atrial natriuretic peptide (ANP) secretion and renal effects in aging. J Gerontol A Biol Sci Med Sci 1997; 52:B196-202
4. Abete P, Cioppa A, Calabrese C, Pascucci I, Cacciatore F, Napoli C, Carno-vale V, Ferrara N, Rengo F: Ischemic threshold and myocardial stunning in the aging heart. Exp Gerontol 1999; 34:875-884
5. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136
6. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87:361-370
7. Murry CE, Richard VJ, Jennings RB, Reimer KA: Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 1991; 260:H796-804
8. Sack S, Mohri M, Arras M, Schwarz ER, Schaper W: Ischaemic precondition-ing-time course of renewal in the pig. Cardiovasc Res 1993; 27:551-555
9. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M: Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72:1293-1299
10. McCully JD, Toyoda Y, Wakiyama H, Rousou AJ, Parker RA, Levitsky S: Age-and gender-related differences in ischemia/reperfusion injury and cardioprotec-tion: Effects of diazoxide. Ann Thorac Surg 2006; 82:117-123
11. Nguyen LT, Rebecchi MJ, Moore LC, Glass PS, Brink PR, Liu L: Attenuation of isoflurane-induced preconditioning and reactive oxygen species production in the senescent rat heart. Anesth Analg 2008; 107:776-782
12. Simkhovich BZ, Marjoram P, Poizat C, Kedes L, Kloner RA: Age-related changes of cardiac gene expression following myocardial ischemia/reperfusion. Arch Biochem Biophys 2003; 420:268-278
13. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004; 5:R80
14. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonu-cleotide array probe level data. Biostatistics 2003; 4:249-264
15. Smyth GK: Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:article 3
16. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402-408
17. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57:289-300
18. Rampil IJ, Moller DH, Bell AH: Isoflurane modulates genomic expression in rat amygdala. Anesth Analg 2006; 102:1431-1438
19. Lee ML, Whitmore GA: Power and sample size for DNA microarray studies. Stat Med 2002; 21:3543-3570
20. Frangogiannis NG, Entman ML: Chemokines in myocardial ischemia. Trends Cardiovasc Med 2005; 15:163-169
21. Okada H, Takemura G, Kosai K, Tsujimoto A, Esaki M, Takahashi T, Nagano S, Kanamori H, Miyata S, Li Y, Ohno T, Maruyama R, Ogino A, Li L, Nakagawa M, Nagashima K, Fujiwara T, Fujiwara H, Minatoguchi S: Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure. Am J Physiol Heart Circ Physiol 2009; 296:H616-26
22. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R: IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 2004; 64:61-71
23. Preston CC, Oberlin AS, Holmuhamedov EL, Gupta A, Sagar S, Syed RH, Siddiqui SA, Raghavakaimal S, Terzic A, Jahangir A: Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphoryla-tion complexes in the heart. Mech Ageing Dev 2008; 129:304-312
24. Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J, De Filippis R, Clerico A: Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation. Cytometry B Clin Cytom 2005; 65:14-21
25. da Silva R, Lucchinetti E, Pasch T, Schaub MC, Zaugg M: Ischemic but not pharmacological preconditioning elicits a gene expression profile similar to unprotected myocardium. Physiol Genomics 2004; 20:117-130
26. Carmel JB, Kakinohana O, Mestril R, Young W, Marsala M, Hart RP: Mediators of ischemic preconditioning identified by microarray analysis of rat spinal cord. Exp Neurol 2004; 185:81-96
27. Simkhovich BZ, Marjoram P, Poizat C, Kedes L, Kloner RA: Brief episode of ischemia activates protective genetic program in rat heart: A gene chip study. Cardiovasc Res 2003; 59:450-459
28. Hsu JC, Bravo R, Taub R: Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol 1992; 12:4654-4665
29. Zhang N, Ahsan MH, Zhu L, Sambucetti LC, Purchio AF, West DB: NF-KB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation. J Biol Chem 2005; 280:21400-21408
30. Felkin LE, Birks EJ, George R, Wong S, Khaghani A, Yacoub MH, Barton PJ: A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support. J Heart Lung Transplant 2006; 25:1413-1419
31. Liao H, Hyman MC, Lawrence DA, Pinsky DJ: Molecular regulation of the PAI-1 gene by hypoxia: Contributions of Egr-1, HIF-1alpha, and C/EBPa. FASEB J 2007; 21:935-949
32. Yoshida Y, Togi K, Matsumae H, Nakashima Y, Kojima Y, Yamamoto H, Ono K, Nakamura T, Kita T, Tanaka M: CCN1 protects cardiac myocytes from oxidative stress via /31 integrin-Akt pathway. Biochem Biophys Res Commun 2007; 355:611-618
33. Grote K, Bavendiek U, Grothusen C, Flach I, Hilfiker-Kleiner D, Drexler H, Schieffer B: Stretch-inducible expression of the angiogenic factor CCN1 in vascular smooth muscle cells is mediated by Egr-1. J Biol Chem 2004; 279:55675-55681
34. Kunz M, Moeller S, Koczan D, Lorenz P, Wenger RH, GlockerMO, Thiesen HJ, Gross G, Ibrahim SM: Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem 2003; 278:45651-45660
35. Sarkar SA, Kutlu B, Velmurugan K, Kizaka-Kondoh S, Lee CE, Wong R, Valentine A, Davidson HW, Hutton JC, Pugazhenthi S: Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-KB) signalling in human islets and in amouse beta cell line. Diabetologia 2009; 52:1092-1101
36. Wootz H, Hansson I, Korhonen L, Lindholm D: XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. Exp Cell Res 2006; 312:1890-1898
37. Dandrea T, Hellmold H, Jonsson C, Zhivotovsky B, Hofer T, Warngard L, Cotgreave I: The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: Relationship to DNA damage, cell cycle arrest, and caspase activation. Free Radic Biol Med 2004; 36:881-896
38. Frangogiannis NG: Chemokines in the ischemic myocardium: From inflammation to fibrosis. Inflamm Res 2004; 53:585-595
39. Frangogiannis NG, Smith CW, Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53:31-47
40. Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N, Wen J, Egashira K, Takeshita A: Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003; 108:2134-2140 (Pubitemid 37337591)
41. Bujak M, Kweon HJ, Chatila K, Li N, Taffet G, Frangogiannis NG: Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol 2008; 51:1384-1392
42. Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE, Ikeda U: Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 2006; 99:891-899
43. Tsutamoto T, HisanagaT, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M: Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998; 31:391-398
44. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML: Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999; 99:546-551
45. Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, AzumaJ, Kishimoto T: Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 1995; 91:1520-1524
46. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R: An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA 2001; 98:9050-9055
47. Smart N, Mojet MH, Latchman DS, MarberMS, Duchen MR, Heads RJ: IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. Cardiovasc Res 2006; 69:164-177
48. Cai D, Xaymardan M, Holm JM, Zheng J, Kizer JR, Edelberg JM: Age-associated impairment in TNF-alpha cardioprotection from myocardial infarction. Am J Physiol Heart Circ Physiol 2003; 285:H463-9
49. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM: Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 2005; 288:H971-6
50. Raphael J, RivoJ, Gozal Y: Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signalling. Br J Anaesth 2005; 95:756-763
51. Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflu-rane-induced preconditioning in vivo: Potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. ANESTHESIOLOGY 2004; 100:532-539
52. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, Scandroglio AM, Maselli D, De Luca M, Marchetti C, Crescenzi G, Zangrillo A: Myocardial damage prevented by volatile anesthetics: A multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006; 20:477-483
53. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, De Luca M, Fochi O, D'Avolio S, Bignami E, Calabro MG, Zangrillo A: Cardiac protection by volatile anaesthetics: A multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007; 24:323-331
54. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. ANESTHESIOLOGY 2003; 98:1315-1327
55. Pouzet B, Lecharny JB, Dehoux M, Paquin S, Kitakaze M, Mantz J, Mena-sche P: Is there a place for preconditioning during cardiac operations in humans? Ann Thorac Surg 2002; 73:843-848
56. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P: Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100:II340-4
57. Van Der Linden PJ, Daper A, Trenchant A, De Hert SG: Cardioprotective effects of volatile anesthetics in cardiac surgery. ANESTHESIOLOGY 2003; 99: 516-517
58. Fellahi JL, Gue X, Philippe E, Riou B, Gerard JL: Isoflurane may not influence postoperative cardiac troponin I release and clinical outcome in adult cardiac surgery. Eur J Anaesthesiol 2004; 21:688-693
59. Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, Cornu C, Lecharny JB, Aussage P, Vicaut E, Pons A, Lehot JJ: Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: A randomized bi-centre trial. Br J Anaesth 2007; 99:624-631